Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of medications commonly used in the treatment of type II diabetes mellitus and, more recently, obesity [1, 2]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.